Literature DB >> 8568306

Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.

J E Shellito1, J K Kolls, R Olariu, J M Beck.   

Abstract

To investigate whether successful host defense against Pneumocystis carinii is dependent on induction of inducible nitric oxide synthase (iNOS) in alveolar macrophages, immunocompetent mice, mice depleted of CD4 lymphocytes with anti-CD4 antibody, and mice with severe combined immunodeficiency (scid) were inoculated intratracheally with P. carinii. Three weeks later, immunocompetent mice had cleared the organisms completely, while CD4 cell-depleted and scid mice were severely infected (scores, 3.6 +/- 0.2 and 2.8 +/- 0.2, respectively). Inflammation scores were significantly higher in CD4 cell-depleted mice (3.4 +/- 0.2) than in scid mice (0.6 +/- 0.2). Minimal iNOS mRNA was detectable in lung tissue from immunocompetent mice; iNOS mRNA was comparable in scid mice and mice inoculated with PBS but was 6-fold higher in CD4 cell-depleted mice. Immunohistochemistry localized iNOS protein to alveolar macrophages in CD4 cell-depleted mice. Thus, iNOS is an unlikely participant in host defense against P. carinii, because enzyme expression does not correlate with either clearance or severity of infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568306     DOI: 10.1093/infdis/173.2.432

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.

Authors:  Y Bergeron; N Ouellet; M Simard; M Olivier; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Chung-Ping Liao; Chadi A Hage; Pamela J Durant; Dennis Tschang; Shao-Hung Wang; Chen Zhang; Chao-Hung Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-17       Impact factor: 6.914

6.  Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia.

Authors:  Shao-Hung Wang; Chen Zhang; Mark E Lasbury; Chung-Ping Liao; Pamela J Durant; Dennis Tschang; Chao-Hung Lee
Journal:  Microbes Infect       Date:  2007-12-28       Impact factor: 2.700

7.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

8.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice.

Authors:  James M Beck; Angela M Preston; Steven E Wilcoxen; Susan B Morris; Anne Sturrock; Robert Paine
Journal:  Infect Immun       Date:  2009-01-05       Impact factor: 3.441

10.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.